Stock Price
1.44
Daily Change
-0.09 -5.88%
Monthly
8.27%
Yearly
8.27%
Q2 Forecast
1.42

Autolus Therapeutics Ltd reported $-70.08M in EBITDA for its fiscal quarter ending in September of 2025.





Ebitda Change Date
AstraZeneca USD 5.23B 272M Sep/2025
Autolus Therapeutics Ltd USD -70.08M 11.23M Sep/2025
Hikma Pharmaceutical USD 369M 84M Dec/2024
Novartis USD 4.77B 1.11B Dec/2025
Roche Holding CHF 12.68B 2.36B Jun/2024
Silence Therapeutics USD -22.49M 69K Jun/2025